Skip to main content

Table 1 Subject characteristics

From: Prognostic predictive values of gemcitabine sensitivity-related gene products for unresectable or recurrent biliary tract cancer treated with gemcitabine alone

Total number

28

Age (years)

 

Median

64

Range

46 to 81

Gender

 

Male

15

Female

13

Primary tumor site

 

Extrahepatic bile duct

18

Gallbladder

10

Recurrence or unresectable

 

Recurrence after surgery

22

Unresectable

6